Potential for bias?
Might the objectivity of the information on the obesity “epidemic” sweeping the world be tainted in green?
The market for obesity treatments will grow five-fold by 2016, according to research firm Decision Resources. The category, worth an estimated $478 million in 2006, will grow to $2.7 billion by 2016 in the US, UK, France, Germany, Italy, Spain, and Japan, the firm projected. Growth will be most rapid in the US, where sales will increase from $222 million in 2006 to nearly $2 billion in 2016….
The sticky wicket, as this report notes, is that most of the pharmaceuticals being developed to take advantage of this growth market, “lack blockbuster potential because they are either associated with safety concerns or are available only in inconvenient injectible formulations.”